Beyond platinum sensitivity: immune-engaging therapies and multidimensional treatment stratification in relapsed small-cell lung cancer
Although platinum sensitivity remains a convenient way to categorize relapsed small-cell lung cancer (SCLC), it no longer captures the full range of factors that may influence response to newer treatments. The interval to relapse still carries useful clinical information because it reflects the initial response, the pa...